MedTrace Logo

Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol

NCT03868202 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-07-12

No results posted yet for this study

Summary

This clinical trial is an investigational research study to determine the ratio of glycosylated FSH21/FSH24 in premenopausal women and postmenopausal women as well as determining if estradiol can increase this ratio in postmenopausal women.

Conditions

  • Follicle Stimulating Hormone Glycosylation
  • Urinary FSH21/FSH24 Ratio
  • Estradiol Effect

Interventions

DRUG

Estradiol Transdermal Product

Hormone replacement therapy will be given to postmenopausal women for up to 1 month.

Sponsors & Collaborators

  • Wichita State University

    collaborator OTHER

  • Eastern Virginia Medical School

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-03
Primary Completion
2019-11-30
Completion
2020-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03868202 on ClinicalTrials.gov